Recent 8-K filings for RPID

• May 19, 2026 21:13 UTC other_material materiality 0.70 neutral item 1.01item 9.01

  RPID raises ~$9M in underwritten common stock and warrant offering; insiders add $140K

  Underwritten offering of 3.58M units (share + two warrants) at $1.955/unit; net proceeds ~$8.9M.

• May 13, 2026 20:33 UTC earnings materiality 0.65 negative item 2.02item 9.01

  Rapid Micro Biosystems Q1 revenue up 11% to $8.0M; net loss widens to $14.3M

  Total revenue $8.0M (+11% YoY); product revenue $5.6M (+36%).

• Mar 12, 2026 23:59 UTC earnings materiality 0.80 positive item 2.02item 7.01item 9.01

  Rapid Micro reports record Q4 revenue $11.3M (+37% YoY); 2026 guidance $37-41M; Samsung Biologics expands Growth Direct

  Q4 total revenue $11.3M (+37% YoY); product revenue $9.3M (+78%).

• Jan 13, 2026 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  Rapid Micro Biosystems pre-announces record Q4 rev $11.3M (+37% YoY); FY rev $33.6M (+20%)

  Q4 2025 total revenue expected ~$11.3M, up ~37% YoY; record multi-system order from Top 20 biopharma customer.

• Nov 07, 2025 23:59 UTC earnings materiality 0.75 positive item 2.02item 9.01

  Rapid Micro Biosystems Q3 revenue $7.8M (+3% YoY); raises FY guidance after record multi-system order

  Q3 2025 revenue $7.8M (+3% YoY); recurring revenue up 32% to $4.8M on record consumables.

• Aug 12, 2025 23:59 UTC debt materiality 0.75 positive item 1.01item 2.02item 2.03item 3.02item 7.01item 9.01

  Rapid Micro Biosystems Q2 revenue $7.3M (+10% YoY); enters $45M term loan with Trinity Capital

  Q2 2025 revenue $7.3M, up 10% YoY; net loss $11.9M ($0.27/sh) vs $12.6M ($0.29) prior year.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.70 · Most common event earnings

4 positive 1 negative 4 neutral

source · RPID on sec.gov